Cancer Research UK logo.
SearchDonate
  • Search

A trial of tiragolumab and atezolizumab for cervical cancer (SKYSCRAPER 04)

Overview

Cancer types:

Cervical cancer

Status:

Closed

Phase:

Phase 2

Details

This trial is comparing having tiragolumab and atezolizumab with atezolizumab on its own for cervical cancer that has come back or spread.

Recruitment start: 28 September 2020

Recruitment end: 10 February 2021

How to join

Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.

Chief investigators

Dr Mary McCormack

Supported by

Roche

Last reviewed: 01 Mar 2021

CRUK internal database number: 17221

Help and support